关注
Hui-Yan Luo
Hui-Yan Luo
在 sysucc.org.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
R Xu, W Wei, M Krawczyk, W Wang, H Luo, K Flagg, S Yi, W Shi, Q Quan, ...
Nature materials 16 (11), 1155-1161, 2017
7942017
Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma …
H Luo, J Lu, Y Bai, T Mao, J Wang, Q Fan, Y Zhang, K Zhao, Z Chen, ...
Jama 326 (10), 916-925, 2021
5092021
DNA methylation markers for diagnosis and prognosis of common cancers
X Hao, H Luo, M Krawczyk, W Wei, W Wang, J Wang, K Flagg, J Hou, ...
Proceedings of the National Academy of Sciences 114 (28), 7414-7419, 2017
4562017
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
H Luo, Q Zhao, W Wei, L Zheng, S Yi, G Li, W Wang, H Sheng, H Pu, ...
Science translational medicine 12 (524), eaax7533, 2020
3722020
Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study
H Luo, G Xu, C Li, L He, L Luo, Z Wang, B Jing, Y Deng, Y Jin, Y Li, B Li, ...
The Lancet Oncology 20 (12), 1645-1654, 2019
3542019
Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression
D Chen, H Ju, Y Lu, L Chen, Z Zeng, D Zhang, H Luo, F Wang, M Qiu, ...
Journal of experimental & clinical cancer research 35, 1-13, 2016
2732016
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
D Wang, H Luo, M Qiu, Z Wang, D Zhang, F Wang, Y Li, R Xu
Medical oncology 29, 3092-3100, 2012
2482012
Liquid biopsy of methylation biomarkers in cell-free DNA
H Luo, W Wei, Z Ye, J Zheng, R Xu
Trends in molecular medicine 27 (5), 482-500, 2021
2302021
High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancers
F Wang, R Xu, B Han, Y Shi, H Luo, W Jiang, T Lin, H Huang, Z Xia, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
1802007
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
X Wei, F Wang, D Zhang, M Qiu, C Ren, Y Jin, Y Zhou, D Wang, M He, ...
BMC cancer 15, 1-11, 2015
1692015
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
D Zeng, J Wu, H Luo, Y Li, J Xiao, J Peng, Z Ye, R Zhou, Y Yu, G Wang, ...
Journal for immunotherapy of cancer 9 (8), 2021
1572021
Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
Z Zeng, H Luo, J Yang, W Wu, D Chen, P Huang, R Xu
Clinical Cancer Research 20 (4), 1042-1052, 2014
1562014
ABO blood group, hepatitis B viral infection and risk of pancreatic cancer
DS Wang, DL Chen, C Ren, ZQ Wang, MZ Qiu, HY Luo, DS Zhang, ...
International journal of cancer 131 (2), 461-468, 2012
1552012
Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer
D Wang, C Ren, M Qiu, H Luo, Z Wang, D Zhang, F Wang, Y Li, R Xu
Tumor biology 33, 749-756, 2012
1512012
Identification of microRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression
D Chen, Z Wang, Z Zeng, W Wu, D Zhang, H Luo, F Wang, M Qiu, D Wang, ...
Hepatology 60 (2), 598-609, 2014
1422014
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
Z Zhang, ZX Wang, YX Chen, HX Wu, L Yin, Q Zhao, HY Luo, ZL Zeng, ...
Genome Medicine 14 (1), 45, 2022
1362022
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer
DL Chen, DS Wang, WJ Wu, ZL Zeng, HY Luo, MZ Qiu, C Ren, DS Zhang, ...
Carcinogenesis 34 (4), 803-811, 2013
1202013
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
HX Wu, ZX Wang, Q Zhao, DL Chen, MM He, LP Yang, YN Wang, Y Jin, ...
Annals of translational medicine 7 (22), 2019
1152019
Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis
F Wang, MM He, YC Yao, X Zhao, ZQ Wang, Y Jin, HY Luo, JB Li, ...
Cell Reports Medicine 2 (9), 2021
1112021
Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer
C Ren, M Qiu, D Wang, H Luo, D Zhang, Z Wang, F Wang, Y Li, Z Zhou, ...
Journal of translational medicine 10, 1-7, 2012
1082012
系统目前无法执行此操作,请稍后再试。
文章 1–20